Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection
AK Hedström - Frontiers in Immunology, 2023 - frontiersin.org
Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for
multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV …
multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV …
The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale
VT Dinh, N Loaëc, A Quillévéré, R Le Sénéchal… - Biochimie, 2023 - Elsevier
Abstract The Epstein-Barr virus (EBV) is the first oncogenic virus described in human. EBV
infects more than 90% of the human population worldwide, but most EBV infections are …
infects more than 90% of the human population worldwide, but most EBV infections are …
Worldwide prevalence of Epstein–Barr virus in patients with Burkitt lymphoma: a systematic review and meta-analysis
Burkitt lymphoma (BL) is a form of B-cell malignancy that progresses aggressively and is
most often seen in children. While Epstein–Barr virus (EBV) is a double-stranded DNA virus …
most often seen in children. While Epstein–Barr virus (EBV) is a double-stranded DNA virus …
[HTML][HTML] T cell-mediated immunity during Epstein–Barr virus infections in children
M Liu, R Wang, Z Xie - Infection, Genetics and Evolution, 2023 - Elsevier
Epstein–Barr virus (EBV) infection is extremely common worldwide, with approximately 90%
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook
Nasopharyngeal carcinoma (NPC) is characterised by its remarkable geographical and
ethnic distribution. The interplay between genetic susceptibility, environmental exposures …
ethnic distribution. The interplay between genetic susceptibility, environmental exposures …
[HTML][HTML] Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
Nucleic acid-based therapeutics are a common approach that is increasingly popular for a
wide spectrum of diseases. Lipid nanoparticles (LNPs) are promising delivery carriers that …
wide spectrum of diseases. Lipid nanoparticles (LNPs) are promising delivery carriers that …
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
Epstein–Barr virus (EBV) is the first reported human oncogenic virus and infects more than
95% of the human population worldwide. EBV latent infection in B lymphocytes is essential …
95% of the human population worldwide. EBV latent infection in B lymphocytes is essential …
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge
Epstein-Barr virus (EBV) is associated with several malignancies, neurodegenerative
disorders and is the causative agent of infectious mononucleosis. A vaccine that prevents …
disorders and is the causative agent of infectious mononucleosis. A vaccine that prevents …
Advancements of the Molecular Directed Design and Structure–Activity Relationship of Ferritin Nanocage
X Xia, H Li, J Zang, S Cheng, M Du - Journal of Agricultural and …, 2024 - ACS Publications
Ferritin nanocages possess remarkable structural properties and biological functions,
making them highly attractive for applications in functional materials and biomedicine. This …
making them highly attractive for applications in functional materials and biomedicine. This …
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is closely
associated with various malignancies. Considering the complex life cycle of EBV …
associated with various malignancies. Considering the complex life cycle of EBV …